INmune Bio (INMB) Insider Trading & Ownership $4.87 +0.11 (+2.31%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends INmune Bio (NASDAQ:INMB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage35.20%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$236,436.60Number OfInsiders Selling(Last 12 Months)0 Get INMB Insider Trade Alerts Want to know when executives and insiders are buying or selling INmune Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INMB Insider Buying and Selling by Quarter Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now INmune Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/30/2024David J MossCFOBuy10,000$5.29$52,900.00 9/12/2024David J MossCFOBuy7,690$6.38$49,062.20 9/12/2024Raymond Joseph TesiCEOBuy15,380$6.38$98,124.40 6/25/2024Scott JudaDirectorBuy5,000$7.27$36,350.00 (Data available from 1/1/2013 forward) INMB Insider Trading Activity - Frequently Asked Questions Who is on INmune Bio's Insider Roster? The list of insiders at INmune Bio includes David J Moss, Raymond Joseph Tesi, Scott Juda, and Timothy J Schroeder. Learn more on insiders at INMB. What percentage of INmune Bio stock is owned by insiders? 35.20% of INmune Bio stock is owned by insiders. Learn more on INMB's insider holdings. Which INmune Bio insiders have been buying company stock? The following insiders have purchased INMB shares in the last 24 months: David J Moss ($118,012.20), Raymond Joseph Tesi ($98,124.40), and Scott Juda ($85,000.00). How much insider buying is happening at INmune Bio? Insiders have purchased a total of 47,570 INMB shares in the last 24 months for a total of $301,136.60 bought. Which INmune Bio insiders have been selling company stock? The following insider sold INMB shares in the last 24 months: Timothy J Schroeder ($110,100.00). How much insider selling is happening at INmune Bio? Insiders have sold a total of 10,000 INmune Bio shares in the last 24 months for a total of $110,100.00 sold. INmune Bio Key ExecutivesDr. Raymond Joseph Tesi M.D. (Age 68)Co-Founder, President, CEO, Chief Medical Officer & Chairman Compensation: $500.5k1 recent tradesMr. David J. Moss M.B.A. (Age 54)CFO, Treasurer & Secretary Compensation: $394.9k2 recent tradesDr. Mark William Lowdell BSc (Age 61)FRCPath, MICR, MSc, Ph.D., Chief Scientific Officer & Chief Manufacturing Officer Compensation: $150.24kMr. Joshua S. Schoonover Esq.General Counsel More Insider Trading Tools from MarketBeat Related Companies Cidara Therapeutics Insider Buying X4 Pharmaceuticals Insider Buying Fortress Biotech Insider Buying Fate Therapeutics Insider Buying Cartesian Therapeutics Insider Buying Aquestive Therapeutics Insider Buying Canopy Growth Insider Buying KalVista Pharmaceuticals Insider Buying Akebia Therapeutics Insider Buying Larimar Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:INMB) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INmune Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
